Physician Assistant · Houston, TX
NPI
1922399294
Since 2011
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
272 services
Medicare patients, 2024
160
Average age 73
Drug cost, 2024
$5.3M
873 prescriptions
Company payments, 2025
$1,280
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victoria S Sukholutsky was code 99213 (office e&m - established), 102 times for 40 patients. In total Victoria S Sukholutsky billed 272 services in 8 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 102 | 40 | $43.01 | $4,387 |
| 99213 Office E&M - Established | Facility | 72 | 58 | $43.80 | $3,153 |
| 38222 Other Organ Systems | Facility | 34 | 34 | $47.57 | $1,617 |
| 99214 Office E&M - Established | Facility | 14 | 12 | $65.90 | $923 |
| 99214 Office E&M - Established | Office | 12 | 11 | $65.72 | $789 |
By year: 2022 $9,088 for 195 services; 2023 $14K for 311 services; 2024 $12K for 272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victoria S Sukholutsky prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 237 prescriptions and refills. In total Victoria S Sukholutsky wrote 873 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 237 | 466 | 60 | $8,545 |
| Calquence Acalabrutinib Maleate | 171 | 171 | 17 | $2.5M |
| Venclexta Venetoclax | 87 | 87 | 17 | $956K |
| Imbruvica Ibrutinib | 62 | 62 | Under 11 | $435K |
| Allopurinol Generic | 39 | 63 | 19 | $230 |
| Brukinsa Zanubrutinib | 31 | 31 | Under 11 | $438K |
| Levofloxacin Generic | 18 | 18 | 13 | $113 |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $2,494 |
| Inqovi Decitabine/Cedazuridine | 11 | 11 | Under 11 | $76K |
| Pantoprazole Sodium Generic | 11 | 17 | Under 11 | $63.64 |
Brand drugs: 425 claims; generic drugs: 448 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victoria S Sukholutsky $1,280 ($1,280 in general payments such as food, travel and fees) from 15 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. SNDX | 2 | $200 |
| Adaptive Biotechnologies Corporation ADPT | 3 | $173 |
| Astellas Pharma US Inc 4503.T | 4 | $128 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $124 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $123 |
| Sobi, Inc SOBI.ST | 4 | $118 |
| GlaxoSmithKline, LLC. GSK | 4 | $104 |
| Lilly USA, LLC LLY | 2 | $60.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $58.1 |
| Azurity Pharmaceuticals, Inc. | 2 | $35.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.